| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 6.366 | 7.011 | 9.061 | 24.843 | 26.762 | 18.085 | 21.750 | 22.091 | 34.048 | 40.493 |
| Total Income - EUR | 5.569 | 25.175 | 9.495 | 25.451 | 26.331 | 41.797 | 36.307 | 28.215 | 46.948 | 48.971 |
| Total Expenses - EUR | 16.978 | 17.830 | 19.903 | 23.184 | 23.337 | 19.769 | 25.076 | 26.134 | 35.937 | 42.932 |
| Gross Profit/Loss - EUR | -11.409 | 7.345 | -10.407 | 2.267 | 2.994 | 22.028 | 11.231 | 2.081 | 11.011 | 6.039 |
| Net Profit/Loss - EUR | -11.600 | 7.097 | -10.498 | 2.016 | 2.726 | 21.862 | 10.872 | 1.799 | 10.549 | 5.594 |
| Employees | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 |
Check the financial reports for the company - Skin Prodexim Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 139 | 34 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 17.291 | 18.338 | 12.896 | 15.614 | 16.622 | 17.165 | 14.861 | 17.842 | 23.497 | 20.613 |
| Inventories | 1.244 | 2.610 | 2.073 | 2.889 | 2.256 | 601 | 1.089 | 1.617 | 3.640 | 2.738 |
| Receivables | 15.881 | 15.166 | 8.950 | 11.558 | 11.248 | 11.796 | 11.233 | 12.208 | 11.533 | 10.870 |
| Cash | 166 | 562 | 1.873 | 1.167 | 3.118 | 4.768 | 2.539 | 4.016 | 8.324 | 7.004 |
| Shareholders Funds | -63.088 | -55.349 | -64.910 | -61.703 | -57.782 | -34.824 | -23.180 | -21.453 | -10.839 | -5.184 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 80.518 | 73.721 | 77.807 | 77.317 | 74.404 | 51.989 | 38.041 | 39.298 | 34.336 | 25.797 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1512 - 1512" | |||||||||
| CAEN Financial Year |
1512
|
|||||||||
Comments - Skin Prodexim Srl